Prof Dr Marjolein Drent (M.)

Kuc, S., Wijnen, P., Erckens, R., Gijs, M., Webers, C. A. B., Bekers, O., & Drent, M. (2024). Clinical Patterns of Sarcoidosis Patients with and without Uveitis: Insights from a Dutch Sarcoidosis Centre. Ocular Immunology and Inflammation, 1-8. Advance online publication. https://doi.org/10.1080/09273948.2024.2369931

Drent, M., Wijnen, P., Bekers, O., & Bast, A. (2024). Is a Vitamin K Epoxide Reductase Complex Subunit 1 (VKORC1) Polymorphism a Risk Factor for Nephrolithiasis in Sarcoidosis? International Journal of Molecular Sciences, 25(8), Article 4448. https://doi.org/10.3390/ijms25084448

Drent, M., Wijnen, P. A., Jessurun, N. T., Harmsze, A. M., Bekers, O., & Bast, A. (2024). Drug-Gene Risk Stratification in Patients with Suspected Drug-Induced Interstitial Lung Disease. Drug Safety, 47(4), 355-363. https://doi.org/10.1007/s40264-024-01400-0

Voortman, M., Drent, M., & Stern, B. J. (2024). Neurosarcoidosis and Neurologic Complications of Sarcoidosis Treatment. Clinics in Chest Medicine, 45(1), 91-103. https://doi.org/10.1016/j.ccm.2023.08.005

Mulder, M. M. G., Schellens, J., Sels, J.-W. E. M., van Rosmalen, F., Hulshof, A.-M., de Vries, F., Segers, R., Mihl, C., van Mook, W. N. K. A., Bast, A., Spronk, H. M. H., Henskens, Y. M. C., van der Horst, I. C. C., ten Cate, H., Schurgers, L. J., Drent, M., & van Bussel, B. C. T. (2023). Higher levels of circulating desphospho-uncarboxylated matrix Gla protein over time are associated with worse survival: the prospective Maastricht Intensive Care COVID cohort. Journal of Intensive Care, 11(1), Article 63. https://doi.org/10.1186/s40560-023-00712-0

Jans, N., & Drent, M. (2023). Sarcoïdose, een vaak miskende aandoening. Huisarts en Wetenschap, 66(9), 32-35. https://doi.org/10.1007/s12445-023-2308-6

Saketkoo, L. A., Russell, A. M., Patterson, K. C., Obi, O. N., & Drent, M. (2023). Sarcoidosis and frailty: recognizing factors that foster holistic resilience. Current Opinion in Pulmonary Medicine, 29(5), 501-511. https://doi.org/10.1097/MCP.0000000000000990

Tana, C., Drent, M., Nunes, H., Kouranos, V., Cinetto, F., Jessurun, N. T., & Spagnolo, P. (2022). Comorbidities of sarcoidosis. Annals of Medicine, 54(1), 1014-1035. https://doi.org/10.1080/07853890.2022.2063375

Saketkoo, L. A., Escorpizo, R., Varga, J., Keen, K. J., Fligelstone, K., Birring, S. S., Alexanderson, H., Pettersson, H., Chaudhry, H. A., Poole, J. L., Regardt, M., LeSage, D., Sarver, C., Lanario, J., Renzoni, E., Scholand, M. B., Lammi, M. R., Kowal-Bielecka, O., Distler, O., ... The Global Fellowship on Rehabilitation and Exercise in Systemic Sclerosis (G-FoRSS) (2022). World Health Organization (WHO) International Classification of Functioning, Disability and Health (ICF) Core Set Development for Interstitial Lung Disease. Frontiers in Pharmacology, 13, Article 979788. https://doi.org/10.3389/fphar.2022.979788

Drent, M., Jessurun, N. T., Wijnen, P. A., Bekers, O., & Bast, A. (2022). Drug-induced comorbidities in patients with sarcoidosis. Current Opinion in Pulmonary Medicine, 28(5), 468-477. https://doi.org/10.1097/MCP.0000000000000889